Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
在南非医护人员中,使用Ad26.COV2.S初次免疫后,异源mRNA-1273加强免疫的安全性、有效性和免疫原性:单臂、开放标签、3期SHERPA研究
期刊:PLOS Global Public Health
影响因子:2.5
doi:10.1371/journal.pgph.0003260
Garrett, Nigel; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Takalani, Azwidhwi; Woeber, Kubashni; Bodenstein, Annie; Jonas, Phumeza; Engelbrecht, Imke; Jassat, Waasila; Moultrie, Harry; Bradshaw, Debbie; Seocharan, Ishen; Odhiambo, Jackline; Khuto, Kentse; Richardson, Simone I; Omondi, Millicent A; Nesamari, Rofhiwa; Keeton, Roanne S; Riou, Catherine; Moyo-Gwete, Thandeka; Innes, Craig; Zwane, Zwelethu; Mngadi, Kathy; Brumskine, William; Naicker, Nivashnee; Potloane, Disebo; Badal-Faesen, Sharlaa; Innes, Steve; Barnabas, Shaun; Lombaard, Johan; Gill, Katherine; Nchabeleng, Maphoshane; Snyman, Elizma; Petrick, Friedrich; Spooner, Elizabeth; Naidoo, Logashvari; Kalonji, Dishiki; Naicker, Vimla; Singh, Nishanta; Maboa, Rebone; Mda, Pamela; Malan, Daniel; Nana, Anusha; Malahleha, Mookho; Kotze, Philip; Allagappen, Jon J; Diacon, Andreas H; Kruger, Gertruida M; Patel, Faeezah; Moore, Penny L; Burgers, Wendy A; Anteyi, Kate; Leav, Brett; Bekker, Linda-Gail; Gray, Glenda E; Goga, Ameena